Over expression of PPP2R2C inhibits human glioma cells growth through the suppression of mTOR pathway

FEBS Letters

Volumn 587, Issue 24, 2013, Pages 3892-3897

  Fan, Yi Ling ^a   Chen, Lei ^a   Wang, Ji ^a   Yao, Qing ^a   Wan, Jie Qing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

B55 Gamma; mTOR; p S6K; PPP2R2C

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MEMBRANE PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE 2A C; PROTEIN PHOSPHATASE 2 REGULATORY SUBUNIT B GAMMA; PROTEIN S6K; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CANCER; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

EID: 84888639815     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.09.029     Document Type: Article

References (22)

1. M. Mumby PP2A: unveiling a reluctant tumor suppressor Cell 130 2007 21 24
2. D. Perrotti, and P. Neviani Protein phosphatase 2A: a target for anticancer therapy Lancet Oncol. 14 2013 e229 e238
3. T. Raabe, and U.R. Rapp Ras signaling: PP2A puts Ksr and Raf in the right place Curr. Biol. 13 2003 R635 R637
4. M. Jaumot, and J.F. Hancock Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions Oncogene 20 2001 3949 3958
5. D. Bae, and S. Ceryak Raf-independent, PP2A-dependent MEK activation in response to ERK silencing Biochem. Biophys. Res. Commun. 385 2009 523 527
6. S. Andrabi, O.V. Gjoerup, J.A. Kean, T.M. Roberts, and B. Schaffhausen Protein phosphatase 2A regulates life and death decisions via Akt in a context-dependent manner Proc. Natl. Acad. Sci. USA 104 2007 19011 19016
7. R. Patel, M. Gao, I. Ahmad, J. Fleming, L.B. Singh, T.S. Rai, A.B. McKie, M. Seywright, R.J. Barnetson, J. Edwards, O.J. Sansom, and H.Y. Leung Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression J. Clin. Invest. 123 2013 1157 1175
8. I. Arrouss, F. Nemati, F. Roncal, M. Wislez, K. Dorgham, D. Vallerand, N. Rabbe, N. Karboul, F. Carlotti, J. Bravo, D. Mazier, D. Decaudin, and A. Rebollo Specific targeting of caspase-9/PP2A interaction as potential new anti-cancer therapy PLoS ONE 8 2013 e60816
9. W. Chen, J.D. Arroyo, J.C. Timmons, R. Possemato, and W.C. Hahn Cancer-associated PP2A alpha subunits induce functional haploinsufficiency and tumorigenicity Cancer Res. 65 2005 8183 8192
10. M.R. Junttila, P. Puustinen, M. Niemelä, R. Ahola, H. Arnold, T. Böttzauw, R. Ala-aho, C. Nielsen, J. Ivaska, Y. Taya, S.L. Lu, S. Lin, E.K. Chan, X.J. Wang, R. Grènman, J. Kast, T. Kallunki, R. Sears, V.M. Kähäri, and J. Westermarck CIP2A inhibits PP2A in human malignancies Cell 130 2007 51 62
11. P. Seshacharyulu, P. Pandey, K. Datta, and S.K. Batra Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer Cancer Lett. 335 2013 9 18
12. Y. Xing, Y. Xu, Y. Chen, P.D. Jeffrey, Y. Chao, Z. Lin, Z. Li, S. Strack, J.B. Stock, and Y. Shi Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins Cell 127 2006 341 353
13. L. Backx, J. Vermeesch, E. Pijkels, T. de Ravel, E. Seuntjens, and H. Van Esch PPP2R2C, a gene disrupted in autosomal dominant intellectual disability Eur. J. Med. Genet. 53 2010 239 243
14. P.J. Eichhorn, M.P. Creyghton, K. Wilhelmsen, H. van Dam, and R. Bernards A RNA interference screen identifies the protein phosphatase 2A subunit PR55gamma as a stress-sensitive inhibitor of c-SRC PLoS Genet. 3 2007 e218
15. E.G. Bluemn, E.S. Spencer, B. Mecham, R.R. Gordon, I. Coleman, D. Lewinshtein, E. Mostaghel, X. Zhang, J. Annis, C. Grandori, C. Porter, and P.S. Nelson PPP2R2C loss promotes castration-resistant prostate cancer growth and is associated with increased prostate cancer-specific mortality Mol. Cancer Res. 2013 14 [Epub ahead of print]
16. D.A. Guertin, and D.M. Sabatini Defining the role of mTOR in cancer Cancer Cell 12 2007 9 22
17. H. Zhou, and S. Huang MTOR signaling in cancer cell motility and tumor metastasis Crit. Rev. Eukaryot. Gene Expr. 20 2010 1 16
18. D.J. Messner, C. Romeo, A. Boynton, and S. Rossie Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells J. Cell. Biochem. 99 2006 241 255
19. A.A. Sablina, and W.C. Hahn SV40 small T antigen and PP2A phosphatase in cell transformation Cancer Metastasis Rev. 27 2008 137 146
20. P.J. Eichhorn, M.P. Creyghton, K. Wilhelmsen, H. van Dam, and R. Bernards A RNA interference screen identifies the protein phosphatase 2A subunit PR55gamma as a stress-sensitive inhibitor of c-SRC PLoS Genet. 3 2007 e218
21. C.Y. Guo, D.L. Brautigan, and J.M. Larner ATM-dependent dissociation of B55 regulatory subunit from nuclear PP2A in response to ionizing radiation J. Biol. Chem. 277 2002 4839 4844
22. R.F. O'Shaughnessy, J.C. Welti, K. Sully, and C. Byrne Akt-dependent Pp2a activity is required for epidermal barrier formation during late embryonic development Development 136 2009 3423 3431